6,7-Dihydroxy-5-nitro-2-oxo-2H-chromene-3-carboxylic acid | 388118-96-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 6,7-Dihydroxy-5-nitro-2-oxo-2H-chromene-3-carboxylic acid
• 英文别名: 6,7-Dihydroxy-5-nitro-2-oxochromene-3-carboxylic acid
• CAS: 388118-96-5
• 化学式: C₁₀H₅NO₈
• 分子量: 267.152
• InChiKey: IJSVLBUFHWZGBU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  150
• 氢给体数：
  3
• 氢受体数：
  8

文献信息

• Coumarin derivatives with comt inhibiting activity
  申请人：——

  公开号：US20030186975A1

  公开（公告）日：2003-10-02

  Compounds of formula (I′) wherein the two OH— substituents in the phenyl moiety are in a position ortho to one another and R1 in a position ortho to one of the hydroxy groups; and X, R 1 to R 6 are as defined in claims, exhibit COMT enzyme inhibiting activity so that they are useful as COMT inhibitors.

  式(I')的化合物，其中苯基上的两个OH-取代基相对位于邻位，R1位于其中一个羟基的邻位；并且X，R1到R6如权利要求所定义的，表现出COMT酶抑制活性，因此它们可用作COMT抑制剂。
• Non-endogeneous, constitutively activated human serotonin receptors and small molecule modualtors thereof
  申请人：——

  公开号：US20030224442A1

  公开（公告）日：2003-12-04

  Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT 2A and human 5-HT 2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT 2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT 2A receptors.

  本文披露了非内源性、常规激活的人类5-HT2A和人类5-HT2C受体形式，以及使用这些受体筛选候选化合物的用途。此外，本文还披露了通过筛选方法鉴定出的作用于5-HT2A受体的候选化合物。更进一步地，本文还披露了一类在5-HT2A受体上发挥作用的新型化合物。
• Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
  申请人：——

  公开号：US20030153004A1

  公开（公告）日：2003-08-14

  Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT 2A and human 5-HT 2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT 2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT 2A receptors.

  本文披露了人类5-HT2A和人类5-HT2C受体的非内源性、持续活化形式，以及使用这些受体筛选候选化合物的用途。此外，本文还披露了通过筛选方法确定的作用于5-HT2A受体的候选化合物。还披露了一类新的作用于5-HT2A受体的化合物。
• COUMARIN DERIVATIVES WITH COMT INHIBITING ACTIVITY
  申请人：ORION CORPORATION

  公开号：EP1301503B1

  公开（公告）日：2004-02-25
• US6107324A
  申请人：——

  公开号：US6107324A

  公开（公告）日：2000-08-22